CDX2 and invasive carcinoma: The immunohistochemical markers CDX2 and CK20 in IPNB and CK20 in IPNG were associated with invasive carcinoma, which suggests that intestinal metaplasia participated in tumorigenesis, and some internal molecular changes of this pathological process also play a role in tumor progression.